QQ客服 官方微博 反馈留言

浏览/检索结果: 共16条，第1-10条 帮助 限定条件 专题：复旦大学上海医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序提交时间升序提交时间降序题名升序题名降序作者升序作者降序 RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients with metastatic renal cell carcinoma (mRCC): anti-vegf cohort subanalysis 会议论文 作者:  Cosgriff, Thomas;  Yang, Lin;  Alyasova, Anna;  Ye, Dingwei;  Karpenko, Andrey 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05 RECORD-4 phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Final OS analysis. 会议论文 作者:  Cosgriff, Thomas;  Yang, Lin;  Alyasova, Anna;  Ye, Dingwei;  Karpenko, Andrey 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 RECORD-4 multicenter phase II trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Anti-VEGF cohort subanalysis 期刊论文 Journal of Clinical Oncology, 2016, 卷号: 34 作者:  Cosgriff T., Yang L., Alyasova A., Ye D., Karpenko A., Li H., Alekseev B., Xie L.-P., Kowalyszyn R.D., Karyakin O., Neron Y.V., Collins L.T., Brechenmacher T., Lin C., Morgan L., Motzer R.J. 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05 RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients with metastatic renal cell carcinoma (mRCC): anti-VEGF cohort subanalysis 会议论文 作者:  Morgan, Liza;  Cosgriff, Thomas;  Yang, Lin;  Alyasova, Anna;  Ye, Dingwei 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 RECORD-4 multicenter phase II trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Anti-VEGF cohort subanalysis. 会议论文 作者:  Cosgriff, Thomas;  Yang, Lin;  Alyasova, Anna;  Ye, Dingwei;  Karpenko, Andrey 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients with metastatic renal cell carcinoma (mRCC): Anti-VEGF cohort subanalysis 期刊论文 BJU International, 2016 作者:  Cosgriff T., Yang L., Alyasova A., Ye D., Karpenko A., Alekseev B., Kowalyszyn R., Karyakin O., Neron Y., Collins L.T., Brechenmacher T., Lin C., Morgan L., Motzer R. 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 RECORD-4 phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Final OS analysis 期刊论文 Journal of Clinical Oncology, 2016, 卷号: 34 作者:  Cosgriff T., Yang L., Alyasova A., Ye D., Karpenko A., Li H., Alekseev B., Xie L.-P., Kowalyszyn R.D., Karyakin O., Neron Y.V., Collins L.T., Brechenmacher T., Lin C., Morgan L., Motzer R.J. 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/13 RECORD-4: A multicenter, phase II trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC) 会议论文 作者:  Motzer, Robert;  Alyasova, Anna;  Ye, Dingwei;  Karpenko, Andrey;  Li, Hanzhong 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19 RECORD-4: Multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Asian versus non-Asian population subanalysis 期刊论文 Annals of Oncology, 2015 作者:  Yang L., Alyasova A., Ye D., Karpenko A., Li H., Alekseev B., Xie L., Kurteva G., Kowalyszyn R.D., Karyakin O., Ner贸n Y.V., Cosgriff T.M., Collins L., Brechenmacher T., Lin J.C., Morgan L., Motzer R. 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19 RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Pooled anti-VEGF cohort subanalysis 会议论文 作者:  Alekseev, B.;  Yang, L.;  Alyasova, A.;  Ye, D.;  Karpenko, A. 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/19